Literature DB >> 16877746

The classification, functions and clinical use of different isoforms of HCG.

Ulf-Håkan Stenman1, Aila Tiitinen, Henrik Alfthan, Leena Valmu.   

Abstract

HCG is composed of two subunits, HCGalpha and HCGbeta. During early pregnancy, HCG stimulates progesterone production in the corpus luteum, and injection of HCG is widely used to induce ovulation in assisted reproduction treatment (ART). Under experimental conditions, the free subunits have been shown to exert functions other than those of HCG, but the relevance of these remains to be determined. Intact HCG, free subunits and degraded forms of these occur in biological fluids, and determinations of these are important for diagnosis and monitoring of pregnancy, pregnancy-related disorders and several types of cancer. Development of optimal methods for the various forms has been hampered by lack of appropriate standards and expression of the concentrations of the various forms in units that are not comparable. Furthermore, the nomenclature for HCG assays is confusing and in some cases misleading. These problems can now be solved; a uniform nomenclature has been established, and new standards are available for HCG, its subunits HCGalpha and HCGbeta, the partially degraded or nicked forms of HCG and HCGbeta, and the beta-core fragment. This review describes the biochemical and biological background for the clinical use of determinations of various forms of HCG. The clinical use of HCG and studies on HCG vaccines are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877746     DOI: 10.1093/humupd/dml029

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  40 in total

1.  Epitope analysis and detection of human chorionic gonadotropin (hCG) variants by monoclonal antibodies and mass spectrometry.

Authors:  Hanne Lund; Elisabeth Paus; Peter Berger; Ulf-Håkan Stenman; Tamara Torcellini; Trine Grønhaug Halvorsen; Léon Reubsaet
Journal:  Tumour Biol       Date:  2013-09-07

Review 2.  First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome.

Authors:  S Shiefa; M Amargandhi; J Bhupendra; S Moulali; T Kristine
Journal:  Indian J Clin Biochem       Date:  2012-10-12

3.  Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.

Authors:  Adetunji T Toriola; Egle Tolockiene; Helena Schock; Helja-Marja Surcel; Anne Zeleniuch-Jacquotte; Goran Wadell; Paolo Toniolo; Eva Lundin; Kjell Grankvist; Annekatrin Lukanova
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

4.  Maternal hormones during early pregnancy: a cross-sectional study.

Authors:  Tianhui Chen; Eva Lundin; Kjell Grankvist; Anne Zeleniuch-Jacquotte; Marianne Wulff; Yelena Afanasyeva; Helena Schock; Robert Johansson; Per Lenner; Goran Hallmans; Goran Wadell; Paolo Toniolo; Annekatrin Lukanova
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

5.  Absence of TGF-β Receptor Activation by Highly Purified hCG Preparations.

Authors:  Hannu Koistinen; Laura Hautala; Katri Koli; Ulf-Håkan Stenman
Journal:  Mol Endocrinol       Date:  2015-10-23

6.  Case report: elevated serum beta human chorionic gonadotropin in a woman with osteosarcoma.

Authors:  Benjamin E Tuy; Abimbola A Obafemi; Kathleen S Beebe; Francis R Patterson
Journal:  Clin Orthop Relat Res       Date:  2008-02-21       Impact factor: 4.176

7.  Analytical and clinical validation of the Immulite 1000 hCG assay for quantitative analysis in urine.

Authors:  Frances L Cate; Courtney Moffett; Ann M Gronowski; David G Grenache; Katherine E Hartmann; Alison Woodworth
Journal:  Clin Chim Acta       Date:  2013-03-05       Impact factor: 3.786

Review 8.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

9.  Profiling the glycoforms of the intact alpha subunit of recombinant human chorionic gonadotropin by high-resolution capillary electrophoresis-mass spectrometry.

Authors:  Dipak Thakur; Tomas Rejtar; Barry L Karger; Nathaniel J Washburn; Carlos J Bosques; Nur S Gunay; Zachary Shriver; Ganesh Venkataraman
Journal:  Anal Chem       Date:  2009-11-01       Impact factor: 6.986

10.  Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).

Authors:  C Tempfer; L-C Horn; S Ackermann; M W Beckmann; R Dittrich; J Einenkel; A Günthert; H Haase; J Kratzsch; M C Kreissl; S Polterauer; A D Ebert; K T M Schneider; H G Strauss; F Thiel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.